These findings suggest that the combination of small molecule NNMT inhibitors with other nutritional supplements, such as the precursors of NAD+, may have the potential to enhance the efficacy of treatment for MetS and minimize the side effects caused by high pharmacological dosages (Roberti et al., 2021). This evidence concerns the gene NNMT and metabolic syndrome.